Maurício Friedrich

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke

Maurício Friedrich, Maurer Pereira Martins, Mariana Dagnino Araújo et al. · Cell Transplantation · 2012 · 160 citations · Full text

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

Hugues Chabriat, Claudio L. Bassetti, Ute C. Marx et al. · The Lancet Neurology · 2020 · 49 citations · Full text

Thrombosis, Neurobiology Of Disease, Ischemic Stroke +14

Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis

Luciano Cabral Albuquerque, Luciane Barreneche Narvaes, Aluísio Antunes Maciel et al. · Journal of Vascular Surgery · 2007 · 36 citations

Vascular Disease, Cerebrovascular Disease, Inflammation +16

Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long‐term treatment of predominantly moderate acne with or without concomitant medication – results from the non‐interventional cohort study <scp>ELANG</scp>

Harald Gollnick, Maurício Friedrich, M. Peschen et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 17 citations · Full text